Oncology Drug Approvals Under Health Canada’s Notice of Compliance With Conditions Policy: A Retrospective Cohort Analysis
Canadian Journal of Health Technologies · 31.05.2024 · 4 (5)
DOI: 10.51731/cjht.2024.909 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Journal of Health Technologies, online erschienen am 31.05.2024. Verfasst von Anna Martin und 12 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref).
Abstract (Originalsprache)
Health Canada’s Notice of Compliance with conditions (NOC/c) policy provides expedited access to promising new therapies for serious conditions. This retrospective cohort analysis sought to examine the use of the NOC/c policy for oncology drugs, to determine whether confirmatory studies are aligned with the approved indication, and to assess the impact of the NOC/c policy by quantifying the number of oncology drugs approved under this policy that become the standard of care treatment for their respective indications. The findings suggest that Health Canada’s NOC/c policy has been successful in providing expedited access to promising new therapies. However, ensuring that confirmatory trials are under way at the time of NOC/c issuance may provide assurance that studies addressing the uncertainty associated with NOC/c will not be unnecessarily prolonged. The inclusion of real-world evidence (RWE) as part of confirmatory evidence may help fill gaps.
Zitieren
APA
Martin, A., Hunt, M., Bloomaert, S., Udayakumar, S., Lu, B., Chatterjee, S., Sathiyabalan, G., Brun, J., Kampman, M., Lambert, L., Mittmann, N., Robinson, K., & Chan, K. K. (2024). Oncology Drug Approvals Under Health Canada’s Notice of Compliance With Conditions Policy: A Retrospective Cohort Analysis. Canadian Journal of Health Technologies, 4(5). https://doi.org/10.51731/cjht.2024.909
Vancouver
Martin A, Hunt M, Bloomaert S, Udayakumar S, Lu B, Chatterjee S, et al. Oncology Drug Approvals Under Health Canada’s Notice of Compliance With Conditions Policy: A Retrospective Cohort Analysis. Canadian Journal of Health Technologies. 2024;4(5). doi:10.51731/cjht.2024.909
BibTeX
@article{Martin2024,
author = {Martin, Anna and Hunt, Melissa and Bloomaert, Scott and Udayakumar, Suji and Lu, Brandon and Chatterjee, Shreya and Sathiyabalan, Gaaya and Brun, Jan and Kampman, Melissa and Lambert, Laurie and Mittmann, Nicole and Robinson, Kelly and Chan, Kevin KW},
title = {Oncology Drug Approvals Under Health Canada’s Notice of Compliance With Conditions Policy: A Retrospective Cohort Analysis},
journal = {Canadian Journal of Health Technologies},
year = {2024},
volume = {4},
number = {5},
doi = {10.51731/cjht.2024.909}
}
EUVIMED